Evidence suggests that exosomes can transfer genetic material between cells. However, their roles in hepatitis B virus （HBV） infection remain unclear. Here, we report that exosomes present in the sera of chronic hep...Evidence suggests that exosomes can transfer genetic material between cells. However, their roles in hepatitis B virus （HBV） infection remain unclear. Here, we report that exosomes present in the sera of chronic hepatitis B （CHB） patients contained both HBV nucleic acids and HBV proteins, and transferred HBV to hepatocytes in an active manner. Notably, HBV nucleic acids were detected in natural killer （NK） cells from both CHB patients and healthy donors after exposure to HBV-positive exosomes. Through real-time fluorescence microscopy and flow cytometry, 1, r-dioctadecyl-3,3,3＇,3＇,-tetramethylindodicarbocyanine, 4-chlorobenzenesulfnate salt （DiD）-Iabeled exosomes were observed to interact with NK cells and to be taken up by NK cells, which was enhanced by transforming growth factor-β treatment. Furthermore, HBV-positive exosomes impaired NK-cell functions, including interferon （IFN）-y production, cytolytic activity, NK-cell proliferation and survival, as well as the responsiveness of the cells to poly （I.C） stimulation. HBV infection suppressed the expression of pattern-recognition receptors, especially retinoic acid inducible gene I （RIG-I）, on NK cells, resulting in the dampening of the nuclear factor KB （NF-KB） and p38 mitogen-activated protein kinase pathways. Our results highlight a previously unappreciated role of exosomes in HBV transmission and NK-cell dysfunction during CHB infection.展开更多
基金This work was supported by grants from the National Basic Research Program of China （No. 2013CB531503）, the Natural Science Foundation of China （Nos. 81172789 and 30972692）.
文摘Evidence suggests that exosomes can transfer genetic material between cells. However, their roles in hepatitis B virus （HBV） infection remain unclear. Here, we report that exosomes present in the sera of chronic hepatitis B （CHB） patients contained both HBV nucleic acids and HBV proteins, and transferred HBV to hepatocytes in an active manner. Notably, HBV nucleic acids were detected in natural killer （NK） cells from both CHB patients and healthy donors after exposure to HBV-positive exosomes. Through real-time fluorescence microscopy and flow cytometry, 1, r-dioctadecyl-3,3,3＇,3＇,-tetramethylindodicarbocyanine, 4-chlorobenzenesulfnate salt （DiD）-Iabeled exosomes were observed to interact with NK cells and to be taken up by NK cells, which was enhanced by transforming growth factor-β treatment. Furthermore, HBV-positive exosomes impaired NK-cell functions, including interferon （IFN）-y production, cytolytic activity, NK-cell proliferation and survival, as well as the responsiveness of the cells to poly （I.C） stimulation. HBV infection suppressed the expression of pattern-recognition receptors, especially retinoic acid inducible gene I （RIG-I）, on NK cells, resulting in the dampening of the nuclear factor KB （NF-KB） and p38 mitogen-activated protein kinase pathways. Our results highlight a previously unappreciated role of exosomes in HBV transmission and NK-cell dysfunction during CHB infection.
